Mixed Protamine Human Insulin 30R 30/70 is a compound premixed insulin preparation, composed of 30% soluble regular human insulin and 70% isophane protamine human insulin.
The short-acting component works rapidly to lower postprandial blood glucose, while the protamine intermediate-acting component maintains long-term stable effect to control fasting blood glucose. It is administrated subcutaneously with stable absorption and reliable hypoglycemic performance. Widely used in clinical and daily management of Type 1 and Type 2 diabetes, suitable for long-term standardized blood sugar regulation.
Directions & Dosage
For subcutaneous injection only. Generally injected 30 minutes before breakfast and dinner. Dosage is individualized according to blood glucose level, body weight, diet and physical condition. Adjust dose strictly under doctor’s supervision; do not inject intravenously.
Indications
- Type 1 diabetes mellitus
- Type 2 diabetes uncontrolled by oral hypoglycemic agents
- Diabetes combined with infection, surgery, trauma or pregnancy
- Diabetic patients requiring daily insulin replacement therapy
- Regulation of both fasting and postprandial blood glucose
Product Advantages
- Fixed ratio: 30% short-acting + 70% protamine intermediate-acting
- Dual control of postprandial and fasting blood sugar
- Stable release, gentle and lasting hypoglycemic effect
- Convenient twice-daily injection regimen
- High-purity human insulin, low side effects and good tolerance
Storage Unopened: Store at 2–8°C refrigerator, do not freeze. In use: Store below 25°C, keep away from sunlight and high temperature, use within validity period.
Warning Subcutaneous injection only, forbidden oral use. Overdose may cause hypoglycemia. Contraindicated in patients with insulin allergy. Must be used under medical guidance with regular blood glucose monitoring. Keep out of reach of children.
